Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Clinical benefits of 7 years of treatment with omalizumab in severe uncontrolled asthmatics.

Authors
Type
Published Article
Journal
Journal of Asthma
1532-4303
Publisher
Informa UK (Taylor & Francis)
Publication Date
Volume
48
Issue
4
Pages
387–392
Identifiers
DOI: 10.3109/02770903.2011.561512
PMID: 21391878
Source
Medline

Abstract

Statistics

Seen <100 times